Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05085171 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease

Study acronym: ENCORE
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Mar 2027 to Mar 1, 2027
    • Study completion date: Sep 2027 to Sep 1, 2027
    • Start date: May 5, 2022 to May 4, 2022
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 2022 to May 5, 2022
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.
Trial Details
NCT Number NCT05085171
Lead Sponsor Makerere University
Collaborators: University of Minnesota
Conditions
(from sponsor)		 The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease
Enrollment 2,400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov